Osteogenesis Imperfecta: Skeletal and Non-skeletal Challenges in Adulthood
- PMID: 38836890
- PMCID: PMC11606788
- DOI: 10.1007/s00223-024-01236-x
Osteogenesis Imperfecta: Skeletal and Non-skeletal Challenges in Adulthood
Abstract
Osteogenesis imperfecta (OI) is a Mendelian connective tissue disorder associated with increased bone fragility and other clinical manifestations most commonly due to abnormalities in production, structure, or post-translational modification of type I collagen. Until recently, most research in OI has focused on the pediatric population and much less attention has been directed at the effects of OI in the adult population. This is a narrative review of the literature focusing on the skeletal as well as non-skeletal manifestations in adults with OI that may affect the aging individual. We found evidence to suggest that OI is a systemic disease which involves not only the skeleton, but also the cardiopulmonary and gastrointestinal system, soft tissues, tendons, muscle, and joints, hearing, eyesight, dental health, and women's health in OI and potentially adds negative affect to health-related quality of life. We aim to guide clinicians as well as draw attention to obvious knowledge gaps and the need for further research in adult OI.
Keywords: Adulthood; Aging; Fractures; Non-skeletal issues; Osteogenesis imperfecta.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: JDH: Investigator, TOPaZ. BL: Investigator, TOPaZ; Advisor and speaker for UCB, Amgen, Gedeon-Richter, speaker for Astra-Zenica and Astellas. LF: None. LLW: none. RJ: None. SSN: None. CR: None. SR: TOPaZ, chief investigator. OS: None. LT: None. EO: Consultancy Amgen, Angitia, Ultragenyx, Sanofi.
Similar articles
-
Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.Osteoporos Int. 2018 Dec;29(12):2781-2789. doi: 10.1007/s00198-018-4663-x. Epub 2018 Aug 24. Osteoporos Int. 2018. PMID: 30143849
-
Extra-Skeletal Manifestations in Osteogenesis Imperfecta Mouse Models.Calcif Tissue Int. 2024 Dec;115(6):847-862. doi: 10.1007/s00223-024-01213-4. Epub 2024 Apr 19. Calcif Tissue Int. 2024. PMID: 38641703 Review.
-
Systematic review of health related-quality of life in adults with osteogenesis imperfecta.Orphanet J Rare Dis. 2023 Feb 22;18(1):36. doi: 10.1186/s13023-023-02643-3. Orphanet J Rare Dis. 2023. PMID: 36814291 Free PMC article.
-
Current and Developing Pharmacologic Agents for Improving Skeletal Health in Adults with Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Dec;115(6):805-811. doi: 10.1007/s00223-024-01188-2. Epub 2024 Mar 12. Calcif Tissue Int. 2024. PMID: 38472351 Review.
-
Skeletal and Non-skeletal Phenotypes in Children with Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Dec;115(6):923-930. doi: 10.1007/s00223-024-01276-3. Epub 2024 Aug 21. Calcif Tissue Int. 2024. PMID: 39167113 Review.
Cited by
-
Osteogenesis Imperfecta from Bench to Bedside and from Cradle to Grave.Calcif Tissue Int. 2024 Dec;115(6):775-776. doi: 10.1007/s00223-024-01304-2. Epub 2024 Nov 20. Calcif Tissue Int. 2024. PMID: 39565402 No abstract available.
-
Management of a Patient with Severe Osteogenesis Imperfecta Undergoing Laparoscopic Cholecystectomy.Calcif Tissue Int. 2025 May 8;116(1):72. doi: 10.1007/s00223-025-01375-9. Calcif Tissue Int. 2025. PMID: 40338352 Free PMC article.
-
Cardiac health, type I collagen, and aging in the oim/oim mouse model of osteogenesis imperfecta and a cohort of adults with OI.Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H565-H580. doi: 10.1152/ajpheart.00535.2024. Epub 2025 Feb 4. Am J Physiol Heart Circ Physiol. 2025. PMID: 39902996 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical